AFFiRiS AG - Product Pipeline Review - 2016

  • ID: 3635585
  • Company Profile
  • 34 pages
  • Global Markets Direct
1 of 4
AFFiRiS AG - Product Pipeline Review - 2016

Summary

The report ‘AFFiRiS AG - Product Pipeline Review - 2016’, provides an overview of the AFFiRiS AG’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by AFFiRiS AG, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of AFFiRiS AG
- The report provides overview of AFFiRiS AG including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses AFFiRiS AG’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features AFFiRiS AG’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate AFFiRiS AG’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for AFFiRiS AG
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding AFFiRiS AG’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

AFFiRiS AG Snapshot

AFFiRiS AG Overview

Key Information

Key Facts

AFFiRiS AG - Research and Development Overview

Key Therapeutic Areas

AFFiRiS AG - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

AFFiRiS AG - Pipeline Products Glance

AFFiRiS AG - Clinical Stage Pipeline Products

Phase I Products/Combination Treatment Modalities

AFFiRiS AG - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

AFFiRiS AG - Drug Profiles

ATH-03

Product Description

Mechanism of Action

R&D Progress

ATH-04

Product Description

Mechanism of Action

R&D Progress

ATH-06

Product Description

Mechanism of Action

R&D Progress

PD-01

Product Description

Mechanism of Action

R&D Progress

PD-03

Product Description

Mechanism of Action

R&D Progress

AD-05

Product Description

Mechanism of Action

R&D Progress

ATH-05

Product Description

Mechanism of Action

R&D Progress

PD-04

Product Description

Mechanism of Action

R&D Progress

Vaccine for Allergic Rhinitis and Asthma

Product Description

Mechanism of Action

R&D Progress

Vaccine for Huntington's Disease

Product Description

Mechanism of Action

R&D Progress

Vaccine for Type 2 Diabetes

Product Description

Mechanism of Action

R&D Progress

Vaccine to Target C5a for Alzheimer's Disease

Product Description

Mechanism of Action

R&D Progress

Vaccine to Target PCSK9 for Hypercholesterolemia

Product Description

Mechanism of Action

R&D Progress

AFFiRiS AG - Pipeline Analysis

AFFiRiS AG - Pipeline Products by Target

AFFiRiS AG - Pipeline Products by Route of Administration

AFFiRiS AG - Pipeline Products by Molecule Type

AFFiRiS AG - Recent Pipeline Updates

AFFiRiS AG - Dormant Projects

AFFiRiS AG - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

AFFiRiS AG, Key Information

AFFiRiS AG, Key Facts

AFFiRiS AG - Pipeline by Indication, 2016

AFFiRiS AG - Pipeline by Stage of Development, 2016

AFFiRiS AG - Monotherapy Products in Pipeline, 2016

AFFiRiS AG - Phase I, 2016

AFFiRiS AG - Preclinical, 2016

AFFiRiS AG - Pipeline by Target, 2016

AFFiRiS AG - Pipeline by Route of Administration, 2016

AFFiRiS AG - Pipeline by Molecule Type, 2016

AFFiRiS AG - Recent Pipeline Updates, 2016

AFFiRiS AG - Dormant Developmental Projects,2016

List of Figures

AFFiRiS AG - Pipeline by Indication, 2016

AFFiRiS AG - Pipeline by Stage of Development, 2016

AFFiRiS AG - Monotherapy Products in Pipeline, 2016

AFFiRiS AG - Pipeline by Target, 2016

AFFiRiS AG - Pipeline by Molecule Type, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll